Alzheimer's disease的例句大全

Unfortunately, as Alzheimer's Disease progresses, the family often bears a heavy burden.

不幸的是, 随着阿尔茨海默症病情的发展, 患者家庭往往会背上沉重的负担.

The Epidemic of Alzheimer's Disease How Can We Manage the Costs?

老年性痴呆症流行病我们如何控制成本?

At postmortem, brain changes typical of Alzheimer's disease were found.

在对其的尸检中, 发现阿尔兹罕默氏病的典型脑部改变.

ANOTHER DISORDER in which prompting neurogenesis might be beneficial is Alzheimer's disease.

促进神经新生可能也有益于另一种脑病变─阿兹海默症.

Researchers say they still do not know what causes Alzheimer's disease.

研究者们还不知道阿尔茨海默症的致病原因.

Sufferers from Alzheimer's disease can't cope at home.

阿尔茨海默氏病的患者不能够在家中自理.

In the early 1960s, Blyton fell victim to Alzheimer's disease.

在19世纪60年代早期，布莱顿患上了老年痴呆症。

This is cerebral atrophy in a patient with Alzheimer's disease.

图示一例阿尔茨海默氏病患者萎缩的大脑.

Press Release from Alzheimer's Association International Conference on Alzheimer's Disease 2008.

新闻稿,来自2008阿尔茨海默氏症协会国际会议.

Cholesterol: a new therapeutic target for Alzheimer s disease?

胆固醇: 阿尔茨海默病治疗的新方向?

About 130 people developed Alzheimer's disease during that time.

在这期间,约有130人患上了早老性痴呆症.

Unfortunately, as Alzheimer's disease progresses the family often bears a heavy burden.

不幸的是, 随着阿尔茨海默症病情的发展,家庭往往背有沉重的负担.

Your loved one may not have Alzheimer's disease.

我们关爱的人不一定就是阿尔茨海默病.

Alzheimer's disease affects millions of people around world.

阿尔茨海默病影响了全球几百万人口.

Alzheimer's disease is the most common cause.

老年痴呆症是最普遍的病因.

Observations on efficacy and safety by the use of RSC in treatment of 30 patients with alzheimer's disease

复方海蛇胶囊治疗阿尔茨海默病的临床疗效及安全性观察

Methods In 30 patients with AD and 30 patients with VD, BPSD were assessed by the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD) and the ( Cohen-) Mansfield Agitation Inventory ( CMAI).

方法对30例AD及30例VD患者，采用Alzheimer病行为症状评定量表（BEHAVE-AD）、Cohen-Mansfield激惹性问卷（CMAI）评定患者BPSD。

Objective: To assess the reliability and validity of the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD).

目的：评定阿尔茨海默病（AD）病理行为评分表（BEHAVE-AD）的信度和效度。

The therapeutic response and side effects were evaluated with the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD) and treatment emergent symptom scale ( TESS).

用AD病理行为评分表评价疗效，药物副作用量表评价不良反应。

Methods 46 patients with AD were assessed with the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD), mini mental state examination ( MMSE) and the clinic dementia rating ( CDR) at the day of hospitalized.

方法46例AD患者在入院当天作AD病理行为评分表（BEHAVE-AD）、简易智力状态检查（MMSE）及临床痴呆评定表（CDR）评定。